| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5582045 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 5 Pages | 
Abstract
												Thoracic manifestations in CLL are common among hospitalized patients. Although infectious pneumonia remains most common, unusual or opportunistic infections may be increasing, and direct lung damage owing to CLL itself or to newer biologic agents are being diagnosed with lung tissue sampling. Recognition of these complications will allow earlier diagnosis, which may change management including removal of offending biologic agents or augmentation of treatment for CLL when infiltrative leukemic cells are present.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Anesthesiology and Pain Medicine
												
											Authors
												Sameer Khanijo, Pragati Tandon, Cristina P. Sison, Seth Koenig, 
											